home
about us
member log-in
contact us

PRODUCTS
MUNICIPAL BONDS
INDEX FUNDS
- Total Asset Fund (TAF)
EVENTS
MARKET RESEARCH

Recent Quotes

View Full List

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Ocuphire Pharma, Inc. - Common Stock (NQ:OCUP)

1.170 UNCHANGED

Last Price Updated: 4:00 PM EDT, Oct 23, 2024 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Ocuphire Pharma, Inc. - Common Stock

< Previous 1 2 3 4 Next >

Ophthalmic Biopharmaceutical Ocuphire Pharma Shifts Focus To Gene Therapy Through Opus Genetics Stock Deal ↗

October 23, 2024

Ocuphire Pharma acquires Opus Genetics, expanding its IRD gene therapy pipeline. The renamed company, Opus Genetics, will trade under "IRD" by late October 2024.

Via Benzinga

Shareholder Alert: Ademi LLP Investigates Whether Ocuphire Pharma, Inc. Is Breaching Its Duties to Its Public Shareholders

October 23, 2024

From Ademi LLP

Via Business Wire

OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q2 2024 ↗

August 13, 2024

OCUP stock results show that Ocuphire Pharma missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.

Via InvestorPlace

These 3 Clinical-Stage Biotech Stocks Can Offer Exponential Gains ↗

June 14, 2024

These biotech stocks, lacking in profitability but seeding huge potential, should be on your watchlist.

Via Talk Markets

Duos Technologies And 2 Other Stocks Under $3 Insiders Are Buying ↗

May 22, 2024

Via Benzinga

Recap: Ocuphire Pharma Q3 Earnings ↗

November 13, 2023

Via Benzinga

A Look Into Healthcare Sector Value Stocks ↗

May 22, 2023

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

May 01, 2023

Via Benzinga

Ocuphire Pharma Inc. (NASDAQ: OCUP) Highlighted for Surprising Price Action

April 04, 2023

Via Investor Brand Network

OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q1 2024 ↗

May 10, 2024

OCUP stock results show that Ocuphire Pharma missed analyst estimates for earnings per share and missed on revenue for the first quarter of 2024.

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

April 11, 2024

Via Benzinga

Design Therapeutics And 2 Other Stocks Under $5 Insiders Are Buying ↗

March 26, 2024

The Dow Jones index closed lower by over 150 points on Monday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders...

Via Benzinga

Topics Stocks

OCUP Stock Earnings: Ocuphire Pharma Misses EPS, Misses Revenue for Q4 2023 ↗

March 15, 2024

OCUP stock results show that Ocuphire Pharma missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023.

Via InvestorPlace

7 Under-the-Radar Biotech Stocks Gearing Up for Liftoff ↗

February 26, 2024

Although the health innovation space can be a risky environment, undervalued biotech stocks can take some of the edge off.

Via InvestorPlace

3 Value Stocks to Buy on the Dip: February 2024 ↗

February 07, 2024

While many investors continue to chase after the latest trends, these underappreciated value stocks to buy could be the true winners.

Via InvestorPlace

Buy Alert: Analysts Say These 3 Growth Stocks Could Double in 2024 ↗

November 30, 2023

Often the best investments are out-of-favor and trade at silly cheap valuations. Check out three such growth stocks with huge upside.

Via InvestorPlace

A Look Into Healthcare Sector Value Stocks ↗

November 20, 2023

Via Benzinga

Overview Of Value Stocks In The Healthcare Sector ↗

November 06, 2023

Via Benzinga

5 Value Stocks In The Healthcare Sector ↗

September 11, 2023

Via Benzinga

Surprise! These 3 Penny Stocks Pack Powerful Financials. ↗

July 10, 2023

While investing in penny stocks carries a rough reputation (to put it nicely), these speculative entities just might surprise you.

Via InvestorPlace

Why Venus Concept Shares Are Trading Lower By Over 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

May 15, 2023

Gainers NeoGames S.A. (NASDAQ: NGMS) shares climbed 113.3% to $27.38 as the company agreed to be acquired by Aristocrat Leisure Limited for $29.50 per share in cash.

Via Benzinga

The 7 Best Stocks Under $10 to Buy in May ↗

May 03, 2023

While quality matters in the market, these best stocks under $10 to buy gives you some potential diamonds in the rough.

Via InvestorPlace

7 Small-Cap Biotech Stocks with Massive Potential ↗

April 27, 2023

Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical.

Via InvestorPlace

Ocuphire Pharma Plunges Following CEO Termination, New Appointment: The Bull, Bear Case ↗

April 21, 2023

Ocuphire Pharma Inc (NASDAQ: OCUP) was plunging over 22% at one point on Friday after the company announced it appointed Rick Rodgers to the role of interim CEO.

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

April 21, 2023

Via Benzinga

Why SAP Shares Are Trading Higher By Around 6%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

April 21, 2023

Gainers Mangoceuticals, Inc. (NASDAQ: MGRX) shares jumped 207% to $2.84. The company announced Thursday, that it's featured on Webull Corporate Communications Service Platform.

Via Benzinga

US Stocks Mostly Lower; Nasdaq Down 50 Points ↗

April 21, 2023

U.S. stocks traded mostly lower this morning, with the Nasdaq Composite dropping around 50 points on Friday. Following the market opening Friday, the Dow traded down 0.03% to 33,777.38 while the NASDAQ...

Via Benzinga

7 Thrilling Biotech Stocks for Aggressive Investors to Buy ↗

April 05, 2023

Amid the noise of the global markets recently, these speculative biotech stocks to buy might trade with a mind of their own.

Via InvestorPlace

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

April 04, 2023

Via Benzinga

Ocuphire Pharma, Inc. (NASDAQ: OCUP) Featured in Coverage of The MicroCap Rodeo’s 3rd Annual Winter Wonderful and Best Ideas Investor Conference

February 22, 2023

Via Investor Brand Network

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Home
About Us
Products
Municipal Bonds
Index Funds
Seminars & Events
Market Research
Contact Us
Member Section
Privacy Policy
Terms & Conditions
Security Notice
Customer Service

Securities offered through Purshe Kaplan Sterling Investments, member FINRA / SIPC, Headquartered at 80 State Street,
Albany, NY 12207
Purshe Kaplan Sterling Investments and Tamar Securities, LLC are not affiliated companies.
Tamar Securities, LLC is a Registered Investment Adviser. Advisory services are only offered to clients or prospective clients where Tamar Securities, LLC
and its representatives are properly licensed or exempt from licensure. Past performance is no guarantee of future returns. Investing involves risk and possible loss of principal capital.
No advice may be rendered by Tamar Securities, LLC unless a client service agreement is in place.

NOT FDIC INSURED. NOT BANK GUARANTEED. MAY LOSE VALUE, INCLUDING LOSS OF PRINCIPAL. NOT INSURED BY ANY STATE OR FEDERAL AGENCY.
Web development by IBCnet.com